Combining two grading systems:the clinical validity and inter-observer variability of the 1973 and 2004 WHO bladder cancer classification systems assessed in a UK cohort with 15 years of prospective follow-up

Autor: Ruth M Gailer, Paul Fineron, Paramananthan Mariappan, David J Watson, K. M. Grigor, Marie O'Donnell, Gordon Smith

Publikováno v: Mariappan, P, Fineron, P, O'Donnell, M, Gailer, R M, Watson, D J, Smith, G & Grigor, K M 2020, ' Combining two grading systems : the clinical validity and inter-observer variability of the 1973 and 2004 WHO bladder cancer classification systems assessed in a UK cohort with 15 years of prospective follow-up ', World journal of urology . https://doi.org/10.1007/s00345-020-03180-5
World Journal of Urology

Purpose Paucity of reliable long-term data on the prognostic implications of the 2004 WHO bladder cancer classification system necessitates utilisation of both this and the 1973 grading systems. This study evaluated, in noninvasive (pTa) bladder tumo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8c74eef62d3c15e1c80afbcb9e28396
https://hdl.handle.net/20.500.11820/522f5e97-6fc4-433d-814c-bc4399c75c8f

Contralateral biopsy in the management of testicular cancer: what we have learned and what we need to improve

Autor: K. M. Grigor, N E Skakkebaek, Niklas Rye Jørgensen, Mikael Rørth, E. Rajpert-De Meyts

Publikováno v: Andrology. 3:99-101

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5feef60016188e134441e1677abbace6
https://doi.org/10.1111/andr.12008

A Randomized Trial of Radical Radiotherapy for the Management of pT1G3 NXM0 Transitional Cell Carcinoma of the Bladder

Autor: K. M. Grigor, Gareth Griffiths, Roger Kockelbergh, D.M.A. Wallace, Howard Kynaston, T. Barlow, Mahesh K. B. Parmar, C. Beacock, S. J. Harland, S. Clawson

Publikováno v: Journal of Urology. 178:807-813

We conducted a multicenter randomized trial in the United Kingdom to determine the efficacy of radical radiotherapy in reducing the incidence of progression of pT1G3 transitional cell carcinoma of the bladder to muscle invasive disease and subsequent

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c89290bc10b67f6fea385b254f7ac186
https://doi.org/10.1016/j.juro.2007.05.024

Can p53 staining be used to identify patients with aggressive superficial bladder cancer?

Autor: Mahesh K. B. Parmar, Gareth Griffiths, Margaret A. Knowles, Angela M. Crook, Urvi D. Vani, John R. W. Masters, K. M. Grigor

Publikováno v: The Journal of Pathology. 200:74-81

Approximately 10% of patients with superficial bladder cancer (pTa/pT1) recur with life-threatening muscle-invasive disease. Identification of these patients has been a major goal of bladder cancer research. In 1994, it was suggested that p53 immunos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f6dbdc838d06c3fa673a206ff5c7dca
https://doi.org/10.1002/path.1293

Genetic Aberrations of NAT2 and Chromosome 8: Their Association with Progression in Transitional Cell Carcinoma of the Urinary Bladder

Autor: K. M. Grigor, Michael W. Stacey, Timothy G. Cooke, John M. S. Bartlett, A.D. Watters, James J. Going, E. Sim

Publikováno v: Urologia Internationalis. 67:235-239

Introduction/Objective: N-acetyltransferase 2 (NAT2), mapped to 8p22, is a polymorphic enzyme which metabolizes aromatic amines. Loss of heterozygosity of 8p22 is associated with an increased risk of bladder cancer. This study evaluated NAT2 and chro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a6e1ebfb3ec2049f28c45721faca7e56
https://doi.org/10.1159/000050995